Axon Enterprise (AXON) Earnings Date & Reports

Key Takeaways

• Axon Enterprise is scheduled to report second-quarter 2026 financial results after the market closes on August 5, 2026.
• Wall Street consensus projects Q2 revenue of approximately $876.5 million and adjusted earnings per share (EPS) of roughly $1.83.
• The company enters the report riding nine consecutive quarters of 30%-plus year-over-year revenue growth, most recently posting $807.4 million in Q1 2026.
• AI-powered products remain a breakout growth driver, with AI-related revenue surging over 700% year over year in the first quarter.
• Investor focus will center on gross margin trends amid ongoing tariff pressures and updated full-year guidance following management's raised 2026 outlook in May.

Earnings Context and Why It Matters

Axon Enterprise (NASDAQ: AXON), the Scottsdale, Arizona-based leader in public safety technology, approaches its second-quarter 2026 report at a pivotal moment. The company has transformed from a TASER device manufacturer into a broad technology ecosystem spanning body cameras, cloud-based digital evidence management, AI-powered productivity tools, counter-drone systems, and real-time operations software. Following a May 2026 earnings release that beat consensus estimates on both revenue and EPS and triggered an approximately 12% post-earnings stock surge, expectations are elevated. Yet the stock remains down roughly 40% from its August 2025 all-time high, making this report a critical checkpoint for investors evaluating whether the growth narrative remains intact against a backdrop of tariff-driven margin pressure and macroeconomic uncertainty.

Earnings Expectations

According to consensus analyst estimates compiled from multiple sources, Axon is expected to report Q2 2026 revenue of approximately $876.5 million, with estimates ranging from $857.4 million to $889.3 million. This would represent roughly 31% year-over-year growth compared to the $668.5 million reported in Q2 2025. On the earnings front, the consensus adjusted EPS estimate stands at approximately $1.83, with projections spanning from $1.53 to $2.18. For context, Axon delivered adjusted EPS of $2.12 in the year-ago quarter, meaning the current consensus implies a year-over-year EPS decline of about 14% — a dynamic largely attributable to elevated stock-based compensation expenses, ongoing tariff impacts on hardware margins, and heavier investments in research and development (R&D).

Beyond headline numbers, investors will closely monitor several operating metrics. Annual recurring revenue (ARR), which reached $1.49 billion in Q1 2026 (up 35.2% year over year), serves as a key gauge of the company's subscription-based software momentum. Segment-level performance in Connected Devices — which includes TASER 10 devices, Axon Body 4 cameras, counter-drone products, and fleet systems — and Software & Services will be scrutinized for growth durability and margin trends. In Q1, adjusted gross margin for Connected Devices declined to 50.4% from 52.8% a year earlier, while Software & Services adjusted gross margin dipped to 75.8% from 77.7%. The Q2 report will reveal whether these margin pressures are stabilizing or intensifying.

Management raised its full-year 2026 revenue growth outlook to 30–32% during the Q1 call, up from 27–30% previously, while maintaining its adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) margin target of approximately 25.5%. Any revision to this guidance — upward or downward — will likely be the single largest catalyst for post-earnings stock movement.

AI Screener

As earnings season unfolds, identifying high-potential stocks before market-moving events can be a time-intensive challenge. Tickeron's AI Screener is an AI-powered stock and ETF discovery tool designed to help traders and investors filter the market using technical patterns, fundamental metrics, volatility profiles, and AI-driven trading signals. Users can scan thousands of securities with customizable filters covering industry classification, market capitalization, technical indicators, price patterns, and performance benchmarks. Whether tracking breakout candidates, trending names, or earnings-season setups, the screener aims to surface relevant trade ideas faster than traditional manual research. Explore the AI Screener to see how data-driven filtering can streamline your market monitoring.

Market Reaction and Investor Sentiment

Investor sentiment heading into the Q2 report is cautiously optimistic but layered with complexity. Axon shares closed the most recent trading session near $528, well below the 52-week high of $885.92 but roughly 55% above the 52-week low of $339.01. The stock's post-Q1 rally demonstrated the market's willingness to reward strong execution, yet the steep discount from prior highs suggests lingering concerns about valuation — the forward price-to-earnings (P/E) ratio remains elevated at over 70 times — and margin durability. Analyst consensus rates the stock a "Moderate Buy," with an average 12-month price target near $725, implying approximately 37% upside from current levels. Key risks include further tariff escalation affecting hardware cost of goods sold, deceleration in AI adoption momentum, slower international expansion, or increased competition in the public safety technology space. The conference call, scheduled for 5:00 p.m. ET on August 5, will be closely parsed for management's tone on the demand environment and margin trajectory.

Forward Outlook and Key Factors to Monitor

Looking beyond the Q2 print, several interconnected factors will shape Axon's trajectory through the remainder of 2026 and into 2027. The company's ability to sustain revenue growth above 30% hinges on continued adoption of its expanding product ecosystem, and the stakes are particularly high given nine straight quarters at that elevated threshold.

The AI narrative remains the most closely watched growth catalyst. In Q1, AI Era Plan product revenue — encompassing tools like Draft One for automated report writing and Axon Assistant — grew more than 700% year over year. Maintaining anything close to that trajectory would reinforce the thesis that Axon is successfully monetizing artificial intelligence as a premium software layer atop its hardware install base. Any deceleration, however, could raise questions about whether the AI opportunity is already partially priced into the stock.

Tariff exposure and gross margin management represent the primary risk factor. Hardware margins in the Connected Devices segment compressed meaningfully in Q1, with management citing global tariff costs as the main headwind. Investors should watch for commentary on whether Axon has made progress in mitigating these costs through supply chain adjustments, pricing actions, or product mix shifts toward higher-margin software and services.

International expansion and enterprise market penetration also warrant attention. International revenue represented 20% of total sales in Q2 2025, up from 16% a year earlier, and growth in markets such as Australia, Latin America, Europe, and Asia remains a long-term opportunity. Meanwhile, Axon's counter-drone business, bolstered by the Dedrone acquisition, saw bookings grow 500% year over year in Q1, signaling strong demand for integrated security solutions beyond traditional law enforcement.

Finally, the company's free cash flow trajectory will be scrutinized. Q1 2026 saw negative free cash flow of $54.1 million, a reversal from positive $2.7 million a year earlier, driven by inventory investment and working capital buildup. Management projects full-year free cash flow of approximately $450 million, implying a significant ramp in the second half. Progress toward that target will be a key indicator of whether Axon's growth investments are translating into sustainable cash generation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations